C4.4A as a biomarker for poor prognosis in non-small cell lung cancer patients with adenocarcinomas

被引：0
|
作者：
Jacobsen, B. [1 ]
Muley, T. [1 ]
Meister, M. [1 ]
Dienemann, H. [1 ]
Christensen, I. J. [1 ]
Santoni-Rugiu, E. [1 ]
Laerum, O. D. [1 ]
Ploug, M. [1 ]
机构：
[1] Copenhagen Univ Hosp, Finsen Lab, Copenhagen N, Denmark
来源：
EUROPEAN JOURNAL OF CANCER | 2011年 / 47卷
关键词：
D O I：
10.1016/S0959-8049(11)72663-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S20 / S20
页数：1
相关论文
共 50 条
  • [1] C4.4A IS A PROGNOSTIC INDICATOR IN NON-SMALL CELL LUNG CANCER PATIENTS WITH ADENOCARCINOMAS
    Jacobsen, Benedikte
    Muley, Thomas
    Meister, Michael
    Dienemann, Hendrik
    Christensen, Ib Jarle
    Santoni-Rugiu, Eric
    Laerum, Ole Didrik
    Ploug, Michael
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S960 - S960
  • [2] Prognostic impact of C4.4A in non-small cell lung cancer
    Jacobsen, B.
    Hansen, L. V.
    Skov, B. G.
    Pappot, H.
    Ploug, M.
    [J]. APMIS, 2008, 116 (05) : 415 - 415
  • [3] Tumour cell expression of C4.4A, a structural homologue of the urokinase receptor, correlates with poor prognosis in non-small cell lung cancer
    Hansen, Line V.
    Skov, Birgit G.
    Ploug, Michael
    Pappot, Helle
    [J]. LUNG CANCER, 2007, 58 (02) : 260 - 266
  • [4] Expression of C4.4A in precursor lesions of non-small cell lung cancer
    Jacobsen, Benedikte
    Santoni-Rugiu, Eric
    Illemann, Martin
    Laerum, Ole Didrik
    Ploug, Michael
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S623 - S624
  • [5] C4.4A Expression Is Associated with a Poor Prognosis of Esophageal Squamous Cell Carcinoma
    Masahisa Ohtsuka
    Hirofumi Yamamoto
    Toru Masuzawa
    Hidekazu Takahashi
    Mamoru Uemura
    Naotsugu Haraguchi
    Junichi Nishimura
    Taishi Hata
    Makoto Yamasaki
    Hiroshi Miyata
    Ichiro Takemasa
    Tsunekazu Mizushima
    Shuji Takiguchi
    Yuichiro Doki
    Masaki Mori
    [J]. Annals of Surgical Oncology, 2013, 20 : 2699 - 2705
  • [6] C4.4A Expression Is Associated with a Poor Prognosis of Esophageal Squamous Cell Carcinoma
    Ohtsuka, Masahisa
    Yamamoto, Hirofumi
    Masuzawa, Toru
    Takahashi, Hidekazu
    Uemura, Mamoru
    Haraguchi, Naotsugu
    Nishimura, Junichi
    Hata, Taishi
    Yamasaki, Makoto
    Miyata, Hiroshi
    Takemasa, Ichiro
    Mizushima, Tsunekazu
    Takiguchi, Shuji
    Doki, Yuichiro
    Mori, Masaki
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2013, 20 (08) : 2699 - 2705
  • [7] Extracellular cytochrome c as a biomarker for monitoring therapeutic efficacy and prognosis of non-small cell lung cancer patients
    Javid, Jamsheed
    Mir, Rashid
    Julka, P. K.
    Ray, P. C.
    Saxena, Alpana
    [J]. TUMOR BIOLOGY, 2015, 36 (06) : 4253 - 4260
  • [8] Increased expression of SOX4 is a biomarker for malignant status and poor prognosis in patients with non-small cell lung cancer
    Wang, Dingmiao
    Hao, Ting
    Pan, Yang
    Qian, Xiaowei
    Zhou, Daixing
    [J]. MOLECULAR AND CELLULAR BIOCHEMISTRY, 2015, 402 (1-2) : 75 - 82
  • [9] Increased expression of SOX4 is a biomarker for malignant status and poor prognosis in patients with non-small cell lung cancer
    Dingmiao Wang
    Ting Hao
    Yang Pan
    Xiaowei Qian
    Daixing Zhou
    [J]. Molecular and Cellular Biochemistry, 2015, 402 : 75 - 82
  • [10] Development of a radiogenomic biomarker for tumor characterization and prognosis in Non-Small Cell Lung Cancer patients
    Singh, Apurva
    Wang, Zhuoyang
    Katz, Sharyn
    Yousefi, Bardia
    Kontos, Despina
    [J]. MEDICAL IMAGING 2021: COMPUTER-AIDED DIAGNOSIS, 2021, 11597
12345